<?xml version="1.0" encoding="UTF-8"?>
<snippetsTree>
 <snippets file="antiviral1\PMC3262966\results\search\drugs\results.xml">
  <result pre="for the analysis of seven antiviral drugs, zanamivir, ribavirin, oseltamivir," exact="oseltamivir" post="carboxylate, amantadine, rimantadine and arbidol, in poultry muscle is"/>
  <result pre="of seven antiviral drugs, zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine," exact="rimantadine" post="and arbidol, in poultry muscle is reported. The antiviral"/>
  <result pre="and proved to be adequate for quantification and confirmation of" exact="zanamivir" post="and ribavirin at 10 μg kg−1, oseltamivir, oseltamivir carboxylate,"/>
  <result pre="to be adequate for quantification and confirmation of zanamivir and" exact="ribavirin" post="at 10 μg kg−1, oseltamivir, oseltamivir carboxylate, amantadine and"/>
  <result pre="confirmation of zanamivir and ribavirin at 10 μg kg−1, oseltamivir," exact="oseltamivir" post="carboxylate, amantadine and rimantadine at levels below 1.0 μg"/>
  <result pre="zanamivir and ribavirin at 10 μg kg−1, oseltamivir, oseltamivir carboxylate," exact="amantadine" post="and rimantadine at levels below 1.0 μg kg−1 and"/>
  <result pre="ribavirin at 10 μg kg−1, oseltamivir, oseltamivir carboxylate, amantadine and" exact="rimantadine" post="at levels below 1.0 μg kg−1 and for qualitative"/>
  <result pre="syndrome (SARS) [13, 14]. Furthermore, it has been shown that" exact="oseltamivir" post="carboxylate (Fig. 1) is not removed or degraded in"/>
  <result pre="Waterfowl are then in a position to ingest the active" exact="oseltamivir" post="carboxylate. This could drive the selection of resistant avian"/>
  <result pre="resistance genes and change of host [16, 17]. Finally, amantadine," exact="oseltamivir" post="and arbidol (Fig. 1) are allegedly being administered to"/>
  <result pre="antiviral drugs in chickens, turkeys and ducks: the amantadines, including" exact="amantadine" post="and rimantadine, and the neuramidase inhibitors, including zanamivir and"/>
  <result pre="amantadines, including amantadine and rimantadine, and the neuramidase inhibitors, including" exact="zanamivir" post="and oseltamivir (Fig. 1) [20]. Fig. 1 Chemical structures"/>
  <result pre="amantadine and rimantadine, and the neuramidase inhibitors, including zanamivir and" exact="oseltamivir" post="(Fig. 1) [20]. Fig. 1 Chemical structures of a"/>
  <result pre="Chemical structures of a zanamivir, b ribavirin, c oseltamivir, d" exact="oseltamivir" post="carboxylate, e rimantadine, f amantadine and g arbidol To"/>
  <result pre="b ribavirin, c oseltamivir, d oseltamivir carboxylate, e rimantadine, f" exact="amantadine" post="and g arbidol To be able to detect extra-label"/>
  <result pre="in biological matrices using mass spectrometry have been published for" exact="zanamivir" post="[21, 22], ribavirin [23–26], oseltamivir [17, 27–30] (some of"/>
  <result pre="using mass spectrometry have been published for zanamivir [21, 22]," exact="ribavirin" post="[23–26], oseltamivir [17, 27–30] (some of them including oseltamivir"/>
  <result pre="spectrometry have been published for zanamivir [21, 22], ribavirin [23–26]," exact="oseltamivir" post="[17, 27–30] (some of them including oseltamivir carboxylate [27,"/>
  <result pre="22], ribavirin [23–26], oseltamivir [17, 27–30] (some of them including" exact="oseltamivir" post="carboxylate [27, 30]), oseltamivir carboxylate only [31], amandatine [32–34],"/>
  <result pre="[17, 27–30] (some of them including oseltamivir carboxylate [27, 30])," exact="oseltamivir" post="carboxylate only [31], amandatine [32–34], some of them including"/>
  <result pre="oseltamivir carboxylate only [31], amandatine [32–34], some of them including" exact="rimantadine" post="[33, 35, 36], and arbidol [37, 38]. Recently, Chan"/>
  <result pre="drugs that are applied in poultry breeding including zanamivir, ribavirin," exact="oseltamivir" post="including its active metabolite oseltamivir carboxylate, amantadine, rimantadine and"/>
  <result pre="poultry breeding including zanamivir, ribavirin, oseltamivir including its active metabolite" exact="oseltamivir" post="carboxylate, amantadine, rimantadine and arbidol. The main difficulty in"/>
  <result pre="zanamivir, ribavirin, oseltamivir including its active metabolite oseltamivir carboxylate, amantadine," exact="rimantadine" post="and arbidol. The main difficulty in the development of"/>
  <result pre="and chemical properties. The antiviral drugs include the extremely polar" exact="zanamivir" post="and ribavirin, whereas arbidol is reasonably non-polar. Furthermore, the"/>
  <result pre="demonstrated. The method was fully validated for zanamivir, ribavirin, oseltamivir," exact="oseltamivir" post="carboxylate, amantadine, rimantadine and arbidol. This is the first"/>
  <result pre="was fully validated for zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine," exact="rimantadine" post="and arbidol. This is the first time a quantitative"/>
  <result pre="cm−1 (Millipore, Billerica, MA, USA). Rimantadine HCl (99% purity) and" exact="amantadine" post="HCl (100% purity) were obtained from Sigma-Aldrich (St. Louis,"/>
  <result pre="(99.3% purity) from Amplachem (Carmel, IN, USA). Zanamivir (100% purity)," exact="ribavirin" post="(99.5% purity), oseltamivir phosphate (98% purity) and oseltamivir carboxylate"/>
  <result pre="Amplachem (Carmel, IN, USA). Zanamivir (100% purity), ribavirin (99.5% purity)," exact="oseltamivir" post="phosphate (98% purity) and oseltamivir carboxylate (98% purity), and"/>
  <result pre="(100% purity), ribavirin (99.5% purity), oseltamivir phosphate (98% purity) and" exact="oseltamivir" post="carboxylate (98% purity), and the internal standards zanamivir-13C15N2, ribavirin-13C5,"/>
  <result pre="100 mg L−1 in MeOH. Stock solutions of zanamivir, ribavirin," exact="oseltamivir" post="carboxylate and their isotopically labelled internal standards were prepared"/>
  <result pre="the LC procedure. Z zanamivir, RB ribavirin, O oseltamivir, OC" exact="oseltamivir" post="carboxylate, AM amantadine, RM rimantadine, AB arbidol A Phenomenex"/>
  <result pre="containing fraction B was placed under the PBA cartridge and" exact="ribavirin" post="was eluted from the cartridge using 4 mL MeOH,"/>
  <result pre="and processed using MassLynx 4.1 software (Waters). Zanamivir-13C15N2, ribavirin-13C5, oseltamivir-d3," exact="oseltamivir" post="carboxylate-d3, amantadine-d15 and rimantadine-d4 were used as the internal"/>
  <result pre="levels using the developed method were compared to the indicated" exact="amantadine" post="concentration in the samples, being approximately 4 μg kg−1"/>
  <result pre="and severe matrix effects, even for late-eluting polar compounds like" exact="zanamivir" post="and ribavirin, were observed (Fig. 3). Fig. 3 Matrix"/>
  <result pre="to no matrix effects Using RP chromatography applying C18 columns," exact="zanamivir" post="eluted at the dead time of the system and"/>
  <result pre="of the system and only slight retention was obtained for" exact="ribavirin" post="(retention factor of 0.4). Although the matrix effects significantly"/>
  <result pre="of 0.4). Although the matrix effects significantly decreased for ribavirin," exact="zanamivir" post="was completely suppressed by matrix constituents (Fig. 3) and"/>
  <result pre="stationary phase, all antiviral drugs, including the most polar compounds" exact="zanamivir" post="and ribavirin obtained retention (retention factor of 3.0 and"/>
  <result pre="all antiviral drugs, including the most polar compounds zanamivir and" exact="ribavirin" post="obtained retention (retention factor of 3.0 and 4.6 respectively)."/>
  <result pre="factor of 3.0 and 4.6 respectively). The matrix suppression for" exact="zanamivir" post="decreased from 100% using zic-HILIC or C18 to 97%"/>
  <result pre="C18 to 97% (Fig. 3) resulting in the detection of" exact="zanamivir" post="in poultry muscle at a concentration of 50 μg"/>
  <result pre="the LC procedure is given in Fig. 2b. Zanamivir and" exact="ribavirin" post="are not or hardly retained by the C18 column,"/>
  <result pre="on the Hypercarb column. After that, on the Hypercarb column," exact="zanamivir" post="and ribavirin are separated from the matrix constituents using"/>
  <result pre="Hypercarb column. After that, on the Hypercarb column, zanamivir and" exact="ribavirin" post="are separated from the matrix constituents using a gradient"/>
  <result pre="compounds are retained on the C18 column. After elution of" exact="zanamivir" post="and ribavirin from the Hypercarb column, the other antiviral"/>
  <result pre="retained on the C18 column. After elution of zanamivir and" exact="ribavirin" post="from the Hypercarb column, the other antiviral drugs are"/>
  <result pre="the Strata-X C and (b) the PBA SPE cartridge Because" exact="ribavirin" post="remains neutral at pH 2, it does not interact"/>
  <result pre="type of material are hard to predict. Ribavirin, oseltamivir, amantadine," exact="rimantadine" post="and arbidol are retained by the PBA cartridge (Fig."/>
  <result pre="are retained by the PBA cartridge (Fig. 4b). Zanamivir and" exact="oseltamivir" post="carboxylate do not interact with the PBA material and"/>
  <result pre="of which is given in Fig. 2a. All compounds except" exact="ribavirin" post="were separated from matrix constituents by retaining them on"/>
  <result pre="basified, centrifuged and applied onto a PBA cartridge to retain" exact="ribavirin" post="in order to separate this drug from matrix constituents"/>
  <result pre="The most striking is the decrease in the suppression for" exact="zanamivir" post="from 85% to 29%. After the sample clean-up procedure,"/>
  <result pre="chromatography only is adequate for the analysis of ribavirin, oseltamivir," exact="oseltamivir" post="carboxylate, rimantadine, amantadine and arbidol, but the matrix effect"/>
  <result pre="adequate for the analysis of ribavirin, oseltamivir, oseltamivir carboxylate, rimantadine," exact="amantadine" post="and arbidol, but the matrix effect for zanamivir is"/>
  <result pre="carboxylate, rimantadine, amantadine and arbidol, but the matrix effect for" exact="zanamivir" post="is still very pronounced and as a result 50"/>
  <result pre="very pronounced and as a result 50 μg kg−1 of" exact="zanamivir" post="in poultry muscle is not detectable using solely RP"/>
  <result pre="blank poultry muscle sample spiked at 10 μg kg−1 with" exact="zanamivir" post="and ribavirin are presented in Fig. 6 and those"/>
  <result pre="muscle sample spiked at 10 μg kg−1 with zanamivir and" exact="ribavirin" post="are presented in Fig. 6 and those of a"/>
  <result pre="SRM chromatograms of (a) blank poultry muscle sample spiked with" exact="zanamivir" post="and ribavirin at 10 μg kg−1 including the internal"/>
  <result pre="of (a) blank poultry muscle sample spiked with zanamivir and" exact="ribavirin" post="at 10 μg kg−1 including the internal standards and"/>
  <result pre="chromatograms of (a) blank poultry muscle sample spiked with oseltamivir," exact="oseltamivir" post="carboxylate, rimantadine, amantadine and arbidol at 2.5 μg kg−1"/>
  <result pre="blank poultry muscle sample spiked with oseltamivir, oseltamivir carboxylate, rimantadine," exact="amantadine" post="and arbidol at 2.5 μg kg−1 including the internal"/>
  <result pre="Hypercarb column was tested. This solely affects the results for" exact="zanamivir" post="and ribavirin, because the RP system remains as it"/>
  <result pre="it is in the column-switch system. The matrix effects of" exact="zanamivir" post="and ribavirin were evaluated after injection of a cleaned"/>
  <result pre="in the column-switch system. The matrix effects of zanamivir and" exact="ribavirin" post="were evaluated after injection of a cleaned extract on"/>
  <result pre="be 39%. It is observed that the matrix effects for" exact="zanamivir" post="using injection on solely the Hypercarb column are increased"/>
  <result pre="set-up, which is advantageous for the analysis of zanamivir. For" exact="ribavirin" post="no statistically significant differences were observed and thus it"/>
  <result pre="39.2 55.7 15 130 61.8 64.7 For zanamivir, ribavirin, oseltamivir," exact="oseltamivir" post="carboxylate, amantadine and rimantadine the linearity in the range"/>
  <result pre="15 130 61.8 64.7 For zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate," exact="amantadine" post="and rimantadine the linearity in the range of 0–20"/>
  <result pre="61.8 64.7 For zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate, amantadine and" exact="rimantadine" post="the linearity in the range of 0–20 μg kg−1"/>
  <result pre="is suitable for the qualitative analysis of arbidol. For oseltamivir," exact="oseltamivir" post="carboxylate, amantadine, rimantadine and arbidol the calculated decision limits"/>
  <result pre="the qualitative analysis of arbidol. For oseltamivir, oseltamivir carboxylate, amantadine," exact="rimantadine" post="and arbidol the calculated decision limits (CCα) vary from"/>
  <result pre="confirmatory analysis of these antiviral drugs at relevant levels. For" exact="zanamivir" post="and ribavirin the calculated CCα values are 8 and"/>
  <result pre="of these antiviral drugs at relevant levels. For zanamivir and" exact="ribavirin" post="the calculated CCα values are 8 and 3 μg"/>
  <result pre="levels are still detectable. The calculated detection capabilities (CCβ) of" exact="zanamivir" post="and ribavirin are 15 and 9 μg kg−1, respectively."/>
  <result pre="still detectable. The calculated detection capabilities (CCβ) of zanamivir and" exact="ribavirin" post="are 15 and 9 μg kg−1, respectively. Even though"/>
  <result pre="9 μg kg−1, respectively. Even though the calculated CCβ for" exact="zanamivir" post="exceeds 10 μg kg−1, samples spiked at 10 μg"/>
  <result pre="10 μg kg−1, samples spiked at 10 μg kg−1 with" exact="zanamivir" post="and ribavirin were found to be non-compliant based upon"/>
  <result pre="kg−1, samples spiked at 10 μg kg−1 with zanamivir and" exact="ribavirin" post="were found to be non-compliant based upon the ion"/>
  <result pre="cases (n = 21) indicating that the calculated CCβ for at least" exact="zanamivir" post="is slightly overestimated and that the method is suitable"/>
  <result pre="and that the method is suitable for confirmatory analysis of" exact="zanamivir" post="and ribavirin at relevant levels as well. From the"/>
  <result pre="the method is suitable for confirmatory analysis of zanamivir and" exact="ribavirin" post="at relevant levels as well. From the theoretical study"/>
  <result pre="critical. The acidic methanol should be at pH ≤ 2 to retain" exact="zanamivir" post="on the Strata-X C material and the alkaline MeOH"/>
  <result pre="should be at least pH 12 for the elution of" exact="amantadine" post="and rimantadine. Incorrect pH results in a severe decrease"/>
  <result pre="sample. These levels are in good agreement with the indicated" exact="amantadine" post="concentration, being approximately 4 μg kg−1 for the poultry"/>
  <result pre="matrix interferences was critical for the detection and quantification of" exact="zanamivir" post="and ribavirin in particular. Because neither compound was sufficiently"/>
  <result pre="was critical for the detection and quantification of zanamivir and" exact="ribavirin" post="in particular. Because neither compound was sufficiently retained by"/>
  <result pre="repeatability and within-lab reproducibility were obtained for zanamivir, ribavirin, oseltamivir," exact="oseltamivir" post="carboxylate, amantadine and rimantadine. For arbidol these paramaters did"/>
  <result pre="within-lab reproducibility were obtained for zanamivir, ribavirin, oseltamivir, oseltamivir carboxylate," exact="amantadine" post="and rimantadine. For arbidol these paramaters did not comply"/>
  <result pre="presented method is suitable for the quantitative confirmatory analysis of" exact="zanamivir" post="and ribavirin at levels as low as 10 μg"/>
  <result pre="is suitable for the quantitative confirmatory analysis of zanamivir and" exact="ribavirin" post="at levels as low as 10 μg kg−1 and"/>
  <result pre="levels as low as 10 μg kg−1 and for oseltamivir," exact="oseltamivir" post="carboxylate, amantadine and rimantadine at a concentration of 1"/>
  <result pre="low as 10 μg kg−1 and for oseltamivir, oseltamivir carboxylate," exact="amantadine" post="and rimantadine at a concentration of 1 μg kg−1."/>
  <result pre="10 μg kg−1 and for oseltamivir, oseltamivir carboxylate, amantadine and" exact="rimantadine" post="at a concentration of 1 μg kg−1. Furthermore, the"/>
  <result pre="AJ Am Med Assoc2006295934936 15.GhoshGCNakadaNYamashitaNTanakaHOseltamivir carboxylate, the active metabolite of" exact="oseltamivir" post="phosphate (Tamiflu), detected in sewage discharge and river water"/>
  <result pre="with the proposed widespread use of TamifluEnviron Health Perspect200711510210617366827 17.FickJLindbergRHTysklindMHaemigPDWaldenströmJWallenstenAOlsenBAntiviral" exact="oseltamivir" post="is not removed or degraded in normal sewage water"/>
  <result pre="mass spectrometric method for the determination of the neuraminidase inhibitor" exact="zanamivir" post="(GG167) in human serumJ Chromatogr B1999732383393 22.BaughmanTMWrightWLHuttonKADetermination of zanamivir"/>
  <result pre="inhibitor zanamivir (GG167) in human serumJ Chromatogr B1999732383393 22.BaughmanTMWrightWLHuttonKADetermination of" exact="zanamivir" post="in rat and monkey plasma by positive ion hydrophilic"/>
  <result pre="23.YehLTNguyenMLourencoDLinCCA sensitive and specific method for the determination of total" exact="ribavirin" post="in monkey liver by high-performance liquid chromatography with tandem"/>
  <result pre="Biomed Anal200538344015907616 24.YehLTNguyenMDadgostariSBuWLinCCLC-MS/MS method for simultaneous determination of viramidine and" exact="ribavirin" post="levels in monkey red blood cellsJ Pharm Biomed Anal2007431057106417029670"/>
  <result pre="specific LC-MS/MS method for the simultaneous measurements of viramidine and" exact="ribavirin" post="in human plasmaJ Chromatography B20068321723 26.SvenssonJOBruchfeldASchvarczRStåhleLDetermination of ribavirin in"/>
  <result pre="viramidine and ribavirin in human plasmaJ Chromatography B20068321723 26.SvenssonJOBruchfeldASchvarczRStåhleLDetermination of" exact="ribavirin" post="in serum using highly selective solid-phase extraction and high-performance"/>
  <result pre="of a liquid chromatographic-tandem mass spectrometric method for determination of" exact="oseltamivir" post="and its metabolite oseltamivir carboxylate in plasma, saliva and"/>
  <result pre="mass spectrometric method for determination of oseltamivir and its metabolite" exact="oseltamivir" post="carboxylate in plasma, saliva and urineJ Chromatogr B Anal"/>
  <result pre="and animal plasma and urineJ Chromatogr B2000745373388 29.YamanakaTYamadaMTsujimuraKKondoTNagataSHoboSKurosawaMMatsumuraTClinical pharmacokinetics of" exact="oseltamivir" post="and its active metabolite oseltamivir carboxylate after oral administration"/>
  <result pre="Chromatogr B2000745373388 29.YamanakaTYamadaMTsujimuraKKondoTNagataSHoboSKurosawaMMatsumuraTClinical pharmacokinetics of oseltamivir and its active metabolite" exact="oseltamivir" post="carboxylate after oral administration in horsesJ Vet Med Sci20076929329617409647"/>
  <result pre="oral administration in horsesJ Vet Med Sci20076929329617409647 30.HeinigKBucheliFSensitive determination of" exact="oseltamivir" post="and oseltamivir carboxylate in plasma, urine, cerebrospinal fluid and"/>
  <result pre="in horsesJ Vet Med Sci20076929329617409647 30.HeinigKBucheliFSensitive determination of oseltamivir and" exact="oseltamivir" post="carboxylate in plasma, urine, cerebrospinal fluid and brain by"/>
  <result pre="brain by liquid chromatography-tandem mass spectrometryJ Chromatogr B2008876129136 31.BahramiGMohammadiBKianiADetermination of" exact="oseltamivir" post="carboxylic acid in human serum by solid phase extraction"/>
  <result pre="liquid chromatography with UV detectionJ Chromatogr B20088643842 32.PingWYi-ZengLBen-MeiCNengZLun-ZhaoYYanYZhi-BiaoYQuantitative determination of" exact="amantadine" post="in human plasma by liquid chromatography-mass spectrometry and the"/>
  <result pre="application in a bioequivalence studyJ Pharm Biomed Anal2007431519152517156962 33.XuMJuWXiaXTanHChenMZhangJXiongNJiangMChenLGongLDetermination of" exact="rimantadine" post="in rat plasma by liquid chromatography/electrospray mass spectrometry and"/>
  <result pre="a pharmacokinetic studyJ Chromatogr B2008864123128 34.FengSTianYZhangZZhangJHuangMChenYRapid simultaneous determination of paracetamol," exact="amantadine" post="hydrochloride, caffeine and chlorpheniramine maleate in human plasma by"/>
  <result pre="by liquid chromatography/ tandem mass spectrometryArzneim Forsch200959869519338139 35.HigashiYUemoriIFujiiYSimultaneous determination of" exact="amantadine" post="and rimantadine by HPLC in rat plasma with pre-column"/>
  <result pre="chromatography/ tandem mass spectrometryArzneim Forsch200959869519338139 35.HigashiYUemoriIFujiiYSimultaneous determination of amantadine and" exact="rimantadine" post="by HPLC in rat plasma with pre-column derivatization and"/>
  <result pre="studiesBiomed Chromatogr20051965566215803448 36.ShuangjinCFangFHanLMingMNew method for high-performance liquid chromatographic determination of" exact="amantadine" post="and its analogues in rat plasmaJ Pharm Biomed Anal2007441100110517553649"/>
 </snippets>
</snippetsTree>
